Ngā hua rapu - Carol Addy

  • E whakaatu ana i te 1 - 8 hua o te 8
Whakamahine hua
  1. 1
    Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies

    Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies mā Melvin Khee‐Shing Leow, Carol Addy, Christos S. Mantzoros

    I whakaputaina 2003
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Hypoadiponectinemia Is Associated with Insulin Resistance, Hypertriglyceridemia, and Fat Redistribution in Human Immunodeficiency Virus-Infected Patients Treated with Highly Active Antiretroviral Therapy

    Hypoadiponectinemia Is Associated with Insulin Resistance, Hypertriglyceridemia, and Fat Redistribution in Human Immunodeficiency Virus-Infected Patients Treated with Highly Active... mā Carol Addy, Alina Gavrila, Sotirios Tsiodras, Kimberly G. Brodovicz, Adolf W. Karchmer, Christos S. Mantzoros

    I whakaputaina 2003
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Plasma Adiponectin Concentrations in Relation to Endometrial Cancer: A Case-Control Study in Greece

    Plasma Adiponectin Concentrations in Relation to Endometrial Cancer: A Case-Control Study in Greece mā Eleni Petridou, Christos S. Mantzoros, Nick Dessypris, Panagiotis Koukoulomatis, Carol Addy, Zannis Voulgaris, George P. Chrousos, Dimitrios Trichopoulos

    I whakaputaina 2003
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation

    Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation mā Chai-Wan Kim, Carol Addy, Jun Kusunoki, Norma N. Anderson, Stanisław Deja, Xiaorong Fu, Shawn C. Burgess, Li Cai, Marcie Ruddy, Manu V. Chakravarthy, Steve Previs, Stuart Milstein, Kevin Fitzgerald, David E. Kelley, Jay D. Horton

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation

    Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation mā Chai-Wan Kim, Carol Addy, Jun Kusunoki, Norma N. Anderson, Stanisław Deja, Xiaorong Fu, Shawn C. Burgess, Li Cai, Marcie Ruddy, Manu V. Chakravarthy, Steve Previs, Stuart Milstein, Kevin Fitzgerald, David E. Kelley, Jay D. Horton

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Errata/Corrigenda
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

    Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults mā Ngozi Erondu, Ira Gantz, Bret J. Musser, Shailaja Suryawanshi, Madhuja Mallick, Carol Addy, Josée Côté, George A. Bray, Ken Fujioka, Harold Bays, Priscilla Hollander, Sandra Sanabria Bohórquez, Waisi Eng, Bengt Långström, Richard Hargreaves, H. Donald Burns, Akio Kanatani, Takehiro Fukami, Douglas J. MacNeil, Keith Gottesdiener, John M. Amatruda, Keith D. Kaufman, Steven B. Heymsfield

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    The effects of elafibranor in people with primary biliary cholangitis: a plain language summary

    The effects of elafibranor in people with primary biliary cholangitis: a plain language summary mā Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy, Ulus Salih Akarca, Mário Reis Álvares‐da‐Silva, Pietro Andreoné, Marco Arrese, Sven Francque, Michael A. Heneghan, Pietro Invernizzi, D. I. Jones, Eric Lawitz, Marlyn J. Mayo, Mark G. Swain, Vı́ctor Vargas, John M. Vierling, Alejandra Villamil, Carol Addy, Julie Dietrich, Sarah Mazain, Bachirou Taddé, Benjamin F. Miller, Jianfen Shu, Claudia O. Zein, Carol L. Roberts, Gail E. Wright, Jörn M. Schattenberg

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

    The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake mā Carol Addy, Hamish Wright, Koen Van Laere, Ira Gantz, Ngozi Erondu, Bret J. Musser, Kaifeng Lu, Jinyu Yuan, Sandra Sanabria Bohórquez, Aubrey Stoch, Cathy Stevens, Tung M. Fong, Inge De Lepeleire, Caroline Cilissen, Josée Côté, Kim Rosko, Isaias Noel Gendrano, Allison Martin Nguyen, Barry Gumbiner, Paul Rothenberg, Jan de Hoon, Guy Bormans, Marleen Depré, Waisi Eng, Éric Ravussin, Samuel Klein, John E. Blundell, Gary Herman, H. Donald Burns, Richard Hargreaves, John A. Wagner, Keith Gottesdiener, John M. Amatruda, Steven B. Heymsfield

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: